Drug Shortage Report for XERESE

Last updated on 2018-06-07 History
Report ID 45574
Drug Identification Number 02404044
Brand name XERESE
Common or Proper name XERESE
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR HYDROCORTISONE
Strength(s) 5% 1%
Dosage form(s) CREAM
Route of administration TOPICAL
Packaging size 5g
ATC code D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-05-02
Estimated end date
Actual end date 2018-06-04
Shortage status Resolved
Updated date 2018-06-07
Company comments
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2018-06-07 French Compare
v13 2018-06-07 English Compare
v12 2018-06-01 French Compare
v11 2018-06-01 English Compare
v10 2018-05-30 French Compare
v9 2018-05-30 English Compare
v8 2018-05-17 French Compare
v7 2018-05-17 English Compare
v6 2018-05-04 French Compare
v5 2018-05-04 English Compare
v4 2018-04-19 French Compare
v3 2018-04-19 English Compare
v2 2018-04-12 French Compare
v1 2018-04-12 English Compare